This book highlights the underlying importance of post-stroke complications during recovery, allowing healthcare professionals managing stroke patients to understand their frequency and identify which patients are at risk of developing such complications. Complications are categorised into neurological and non-neurological, and the time-frame for these complications both in the short-term and long-term are discussed. The common practices in managing post-stroke complications and the skills required in their prevention are described, as is the evidence base from clinical trials around their management. The book concludes with a discussion of new developments and research priorities for the future. Management of Post-Stroke Complications is aimed at members of the multidisciplinary stroke team, stroke physicians, neurologists, general practitioners, stroke specialists in training, and medical students.

Medicine for MRCP provides a comprehensive review of the material that you need to pass the MRCP Parts 1 and 2 written papers. The twenty-seven chapters mapped out to the RCP syllabus, cover all areas from molecular medicine and genetics, through to medical law and ethics. Written by specialist contributors and educational experts, the content is carefully crafted to build your understanding for both papers. Each chapter begins with the basic science required for Part 1, before covering clinical medicine for Part 1, Part 2 and the PACES examinations. To ensure effective revision, material is presented in short sections with bullet lists, tables, and boxes. Over 150 drawings and photos illustrate key principles and clinical topics making them easier to retain. References to evidence-based protocols and directions to further reading allow for deeper understanding. Candidates can review their progress via the 180 end-of chapter self-assessment questions. Drawing on the authors' expertise, Medicine for MRCP is the ideal companion for the MRCP as well as a useful reference guide for practicing medical doctors.

The importance of lowering blood pressure in hypertensive subjects is well known and studies suggest that lowering of blood pressure in patients who may already be in the normotensive range further reduces the risk of vascular events, particularly stroke. Epidemiological data have also shown that lower blood pressure and antihypertensive treatment may be associated with cognitive impairment once cerebrovascular disease is established. However, the relationship between hypertension and cerebrovascular disease is more complex than suggested by epidemiological or intervention studies and this book investigates the relationship between blood pressure, white matter disease load and cognitive performance in patients with cerebral small vessel disease.